TWD 28.95
(-9.95%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 46.02 Million TWD | -77.05% |
2022 | 200.55 Million TWD | -56.55% |
2021 | 461.58 Million TWD | 14.87% |
2020 | 401.83 Million TWD | -5.42% |
2019 | 424.85 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 17.87 Million TWD | 3.64% |
2024 Q1 | 17.24 Million TWD | 142.66% |
2023 Q4 | -40.43 Million TWD | -228.93% |
2023 FY | 46.02 Million TWD | -77.05% |
2023 Q2 | 28.26 Million TWD | 5.32% |
2023 Q1 | 26.83 Million TWD | -68.65% |
2023 Q3 | 31.36 Million TWD | 10.97% |
2022 FY | 200.55 Million TWD | -56.55% |
2022 Q4 | 85.59 Million TWD | 0.0% |
2021 FY | 461.58 Million TWD | 14.87% |
2020 FY | 401.83 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -13888.754% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 63.952% |
Level Biotechnology Inc. | 151.99 Million TWD | 69.72% |
Sagittarius Life Science Corp | 135.85 Million TWD | 66.123% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | 39.331% |
TaiMed Biologics Inc. | 225.23 Million TWD | 79.566% |
GlycoNex Incorporation | 995 Thousand TWD | -4525.427% |
VBI | 32.55 Million TWD | -41.37% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 82.083% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 76.3% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 61.619% |
Visgeneer Inc. | 67.48 Million TWD | 31.8% |
Mycenax Biotech Inc. | -375.19 Million TWD | 112.267% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 90.978% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 27.98% |
Neith Corporation | 66.87 Million TWD | 31.179% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 96.813% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -56.797% |
Enimmune corporation | 220.1 Million TWD | 79.09% |
TaiRx, Inc. | 217.13 Million TWD | 78.804% |
CHO Pharma, Inc. | 268.99 Million TWD | 82.891% |
EirGenix Inc. | 236.74 Million TWD | 80.56% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 55.896% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 87.131% |
Lin BioScience, Inc. | 1.09 Billion TWD | 95.804% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 82.708% |
Feng Chi Biotech Corp. | 49.47 Million TWD | 6.97% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -4149.584% |
Lukas Biomedical Inc. | 177.45 Million TWD | 74.064% |
RBC Bioscience Corporation | 58.35 Million TWD | 21.134% |
BiOptic Inc. | 108.69 Million TWD | 57.657% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -51036.667% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 33.637% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -1659.962% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 92.853% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 50.691% |
NaviFUS Corp. | 11.82 Million TWD | -289.135% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 75.87% |
Sinew Pharma Inc. | 186.25 Million TWD | 75.29% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 37.826% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 79.118% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -10.95% |
AP Biosciences Inc | 32.25 Million TWD | -42.694% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 97.513% |
3D Global Biotech Inc. | 5.27 Million TWD | -772.639% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 85.497% |
Intech Biopharm Corporation | -163.99 Million TWD | 128.064% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 95.924% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -10.947% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 72.857% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 68.697% |
TCI GENE Inc. | 174.61 Million TWD | 73.643% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -255583.333% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 84.707% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 84.182% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 45.175% |
PharmaEngine, Inc. | 441.78 Million TWD | 89.583% |
Savior Lifetec Corporation | 223.36 Million TWD | 79.396% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 82.215% |
OBI Pharma, Inc. | 2.01 Billion TWD | 97.717% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 66.859% |
Acepodia, Inc. | 452.56 Million TWD | 89.831% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 91.492% |